Showing results (31-40 of 174) with videos related to

Sort By:
Pageof 18
Blood Advances|November 14, 2022
A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCLHua-Jay J Cherng, Stefan K Alig, Yasuhiro Oki, et al.
Oncotarget|July 11, 2018
Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysisDai Chihara, Nathan H Fowler, Yasuhiro Oki, et al.
Frontiers in Oncology|March 14, 2025
Tumor gene expression signatures associated with outcome in large B-cell lymphoma treated with CD19-directed CAR T-cell therapy (axicabtagene ciloleucel)Yuan Tian, Justin Budka, Frederick L Locke, et al.
Blood Advances|November 7, 2025
Clinical Trial Success Rate in Lymphoma: Fate of Trials and Agents from 2000 to 2019Zhiping Luo, Meng Li, Brian Primeaux, et al.
Transplantation and Cellular Therapy|October 28, 2023
Results from a Phase 1 Study of ACTR707 in Combination with Rituximab in Patients with Relapsed or Refractory CD20+ B Cell LymphomaJavier Munoz, Ian W Flinn, Jonathon B Cohen, et al.
Cancer|November 20, 2023
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 studyMax J Gordon, Lei Feng, Paolo Strati, et al.
Blood Cancer Discovery|June 24, 2026
A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell LymphomaHaopeng Yang, Kotaro Arita, Kevin Bowman, et al.
Blood|December 16, 2004
MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cellsLiza Ho, R Eric Davis, Béatrice Conne, et al.
Blood|March 13, 2012
The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell linesManuela Lemoine, Enrico Derenzini, Daniela Buglio, et al.
Leukemia Research|May 15, 2013
XIAP downregulation promotes caspase-dependent inhibition of proteasome activity in AML cellsBing Z Carter, Duncan H Mak, Zhiqiang Wang, et al.
Pageof 18